Advertisement

Zerebrale Mikroangiopathien

  • E. B Ringelstein

Zusammenfassung

Es ist berechtigt, zerebrale Mikroangiopathien von anderen Verschlusskrankheiten der Hirnarterien und der hirnversorgenden Arterien abzugrenzen, weil sie in Bezug auf die erforderliche Diagnostik, das Risikoprofil, die Prognose und auch die Therapie distinkte Entitäten darstellen. Auch weist der klinische Phänotyp, d.h. die Symptomatik, charakteristische Merkmale auf, die oft schon eine Abgrenzung dieser Krankheitsgruppe von anderen Insultursachen am Krankenbett erlauben.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Adair J, Graham G, Hart B, Kornfeld M, Ptacel L, Davis L (1997) Hereditary neuropsychiatric syndrome secondary to familial vascular leucoence-phalopathy. Neurology 48:A99Google Scholar
  2. 2.
    Akiguchi I, Tomimoto H, Suenaga T, Wakita H, Butka H (1997) Alterations in glia and axons in the brains of Binswanger’s disease patients. Stroke 28:1423–1429PubMedGoogle Scholar
  3. 3.
    Awad LA, Spetzler RF, Hodak JA, Awad CA, Carey R (1986) Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I: Correlation with age and cerebrovascular risk factors. Stroke 17:1084–1089PubMedGoogle Scholar
  4. 4.
    Awad LA, Johnson PC, Spetzler RF, Hodak JA (1986) Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II: Postmortem pathological correlations. Stroke 17:1090–1097PubMedGoogle Scholar
  5. 5.
    Babikian V, Ropper AH (1987) Binswanger’s disease: a review. Stroke 18:2–12PubMedGoogle Scholar
  6. 6.
    Bales KR, Verina T, Dodel RC, Yansheng D, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, Piccardo P, Ghetti B, Paul SM (1997) Lack of apolipoprotein E dramatically reduces amyloid-β-peptid deposition. Nat Gen 17:263–264Google Scholar
  7. 7.
    Baudrimont M, Dubas IF, Joutel A, Tournier-Laserve E, Bousser M-G (1993) Autosomal dominant leucoencephalopathy and subcortical ischemic stroke: a clinicopathological study. Stroke 24:122–125PubMedGoogle Scholar
  8. 8.
    Bergmann M, Ebke M, Yuan Y, Brück W, Mugler M, Schwendemann G (1996) Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leucoencephalopathy (CADASIL): a morphological study of a German family. Acta Neuropathol 92:341–350PubMedGoogle Scholar
  9. 9.
    Boiten J, Lodder J (1991) Lacunar infarcts. Pathogenesis and validity of the clinical syndromes. Stroke 22:1374–1378Google Scholar
  10. 10.
    Boone KB, Miller BL, Lesser IM, Mehringer CM, Vill-Gutirerez E, Goldberg MA, Bergman NG (1992) Neuropsychological correlates of white-matter lesions in healthy subjects: a threshold effect. Arch Neurol 49:549–554PubMedGoogle Scholar
  11. 11.
    Breteler MMB, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout, van Harskamp F, Tanghe HLJ, de Jong PTVM, van Gijn J, Hofmann A (1994) Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam study. Neurology 44:1246–1252PubMedGoogle Scholar
  12. 12.
    Cadelo M, Inzitari D, Pracucci G, Mascalchi M (1991) Predictors of leucoaraiosis in elderly neurological patients. Cerebrovasc Dis 1:345–351Google Scholar
  13. 13.
    Caplan LR (1995) Binswanger’s disease — revisited. Neurology 45:626–633PubMedGoogle Scholar
  14. 14.
    Chabriat H, Vahedi K, Iba-Citzen MT, Joutel A, Nibbio A, Nagy TG, Krebs MO, Julien J, Dubois B, Ducrocq X, Levasseur M, Homeyer P, Mas JL, Lyon-Caen O, Tournier-Laserve E, Bousser M-G (1995) Clinical spectrum of CADASIL. A study of 7 families. Lancet 346:934–939PubMedGoogle Scholar
  15. 15.
    Dahlöf B, Lindholm H, Hannsson L, Schersten B, Eckbom T, Wester PO (1991) Morbidity and mortality in the Swedish trial in old patients with hypertention (STOP hypertension). Lancet 338:1281–1285PubMedGoogle Scholar
  16. 16.
    Damian MS, Reichmann H, Scibel P, Bachmann G, Schachenmayr W, Dorndorf W (1994) Das MELAS-Syndrom. Klinik, MRT, Biochemie und Molekulargenetik. Nervenarzt 65:258–263Google Scholar
  17. 17.
    Damian MS, Scibel P, Reichmann H, Schachenmayr W, Laube H, Bachmann G, Wassili KH, Dorndorf W (1995) Clinical spectrum of the „ME-LAS“-mutation in a large German family. Acta Neurol Scand 92:409–415PubMedGoogle Scholar
  18. 18.
    Davous P, Fallet-Ianco C (1991) Démence souscorticale familiale avec leucencéphalopathie artériopa-tique: observation clinico-pathologique. Rév Neurol 147:376–384PubMedGoogle Scholar
  19. 19.
    De Reuck J, Crevits L, De Coster W, Sieben G, van der Eecken H (1980) Pathogenesis of Binswanger chronic progressive subcortical encephalopathy. Neurology 30:920–928PubMedGoogle Scholar
  20. 20.
    Desnik RJ (1993) Fabry disease: alpha-galactosidase A deficiency. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL, Kunkel LM (eds) The molecular and genetic basis of neurological disease. Butterworth-Heinemann, Boston, pp 505–513Google Scholar
  21. 21.
    Dichgans M, Mayer M, Müller-Myhsok B, Straube A, Gasser T (1996) Identification of Key Recombinant Narrows with CADASIL Gene Region to 8cM and Argues against Allelysm of CADASIL and Familial Hemiplegic Migraine. Genomics 32:151–154PubMedGoogle Scholar
  22. 22.
    Duncan R, Hadley D, Bone I, Symonds EM, Worthington BS, Rubin PC (1989) Blindness in eclampsia: CT-and MR-imaging. J Neurol Neuro-surg Psychiatr 52:899–902Google Scholar
  23. 23.
    Ebke M, Dichgans M, Bergmann M, Voelter HU, Rieger P, Gasser T, Schwendemann G (1997) CADASIL: skin biopsy allows diagnosis in early stages. Acta Neurol Scand 95:351–357PubMedGoogle Scholar
  24. 24.
    Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, Heyman A (1996) Cerebral amyloid-angiopathy in the brains of patients with Alzheimer’s disease: the CERAD-experience, part XV. Neurology 46:1592–1596PubMedGoogle Scholar
  25. 25.
    Erkinyuntti T, Gao F, Lee DH, Eliasziw M, Merskey H, Hachinski VC (1994) Lack of difference in brain hyperintensities between patients with early Alzheimer’s disease and control subjects. Arch Neurol 51:260–268Google Scholar
  26. 26.
    Estes ML, Chimowitz NI, Awad IA, MacMahon JT, Furlan AJ; Ratliff NB (1991) Sclerosing vasculopathy of the central nervous system in non-elderly demented patients. Arch Neurol 48:631–636PubMedGoogle Scholar
  27. 27.
    Evers S, Koch H-G, Grotemeyer K-H, Lange B, Deufel T, Ringelstein EB (1997) Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia. Arch Neurol 54:1276–1282PubMedGoogle Scholar
  28. 28.
    Fabry J (1898) Beitrag zur Kenntnis der Purpura hemoragica nodulares (Purpura papulosa hemor-rhagica Hebrae). Arch Dermatol Suff 43:187Google Scholar
  29. 29.
    Fisher CM (1965) Lacunes: Small deep cerebral infarcts. Neurology 15:774–784PubMedGoogle Scholar
  30. 30.
    Fisher CM (1969) The arterial lesions underlying lacunes. Acta Neuropathol (Berlin) 12:1–15Google Scholar
  31. 31.
    Fisher CM (1979) Capsular infarcts. The underlying vascular lesions. Arch Neurol 36:65–73PubMedGoogle Scholar
  32. 32.
    Fisher CM (1982) Lacunar stroke and infarcts: a review. Neurology 32:871–876PubMedGoogle Scholar
  33. 33.
    Fisher CM (1989) Binswanger’s encephalopathy: a review. J Neurol 236:65–79PubMedGoogle Scholar
  34. 34.
    Foulkes MA, Wolf PA, Price TR (1988) The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 19:547–554PubMedGoogle Scholar
  35. 35.
    Fountain NB, Eberhard DA (1996) Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: report of new cases and review of the literature. Neurology 46:190–197PubMedGoogle Scholar
  36. 36.
    Fukutake T, Hirayama K (1995) Familial youngadult onset arteriosclerotic leucoencephalopathy with alopecia and lumbago without arterial hypertension. Eur Neurol 35:69–79PubMedGoogle Scholar
  37. 37.
    Furby A, Vahedi K, Force M, Larrouy S, Ruchoux MM, Joutel A, Tournier-Lasserve E (1998) Differential diagnosis of a vascular leukoencephalopathy within a CADASIL family: use of skin biopsy electron microscopy study and direct genotypic screening. J Neurol 245:734–740PubMedGoogle Scholar
  38. 38.
    Furuta A, Ishii N, Nishihara Y, Horie A (1991) Medullary arteries in aging and dementia. Stroke 22:442–446PubMedGoogle Scholar
  39. 39.
    Goto Y, Horai S, Matsuoka T, Koga Y, Nihei K, Kobayashi M, Nonaka R (1992) Mitochondrial myopathy, encephalopathy, lactid acidosis, and strokelike episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 42:545–550PubMedGoogle Scholar
  40. 40.
    Graffagnino C, Herbstreith MH, Schmechel DE, Levy E, Roses AD, Alberts MJ (1995) Cystatin C mutation in an elderly man with sporadic amyloid angiopathy and intracerebral hemorrhage. Stroke 26:2190–2193PubMedGoogle Scholar
  41. 41.
    Greenberg SM, Vonsattel JPG, Starkes JW, Gruber M, Finklestein SP (1993) The clinical spectrum of cerebral amyloid angiopathy: presentations with outlobar hemorrhage. Neurology 43:2073–2079PubMedGoogle Scholar
  42. 42.
    Greenberg SM, Vonsattel JPG (1997) Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. Stroke 28:1418–1422PubMedGoogle Scholar
  43. 43.
    Greenberg SM, Vonsattel JPG, Segal AZ (1998) Association of apolipoprotein E, epsilon2 and vascu-lopathy in cerebral amyloid angiopathy. Neurology 50:961–965PubMedGoogle Scholar
  44. 44.
    Greenberg SM (1998) Cerebral amyloid angiopathy. Prospects for clinical diagnosis and treatment. Neurology 51:690–694PubMedGoogle Scholar
  45. 45.
    Grotta J, Norris JW, Kamm B (1992) Prevention of stroke with ticlopidine: who benefits most? Neurology 42:111–115PubMedGoogle Scholar
  46. 46.
    Hachinski VC, Potter P, Merkskey H (1987) Leu-coaraiosis. Arch Neurol 44:21–23PubMedGoogle Scholar
  47. 47.
    Heiskala H, Somer H, Kovanan J, Poutiainen E, Karli H, Haitia M (1988) Microangiopathy with encephalopathy, hearing loss and retinal arteriolar occlusions: two new cases. J Neurol Sci 86:239–250PubMedGoogle Scholar
  48. 48.
    Hendriks L, Van Duijn CM, Kras P (1992) Presenile dementia and cerebral hemorrhage linked to a mutation of codon 692 in the β-amyloid-precursor-protein-gene. Nat Gen 1:218–221Google Scholar
  49. 49.
    Inzitari D, Diaz F, Vox A, Hachinski VC, Steingart A, Lau C, Donald A, Wade J, Mulic H, Merskey H (1987) Vascular risk factors and leucoaraiosis. Arch Neurol 44:42–47PubMedGoogle Scholar
  50. 50.
    Jen J, Cohen AH, Stout JT, Vinters HV, Melson S, Baloh RW (1997) Hereditary Endotheliopathy with Retinopathy, Nephropathy and Stroke (HERNS). Neurology 49:1322–1330PubMedGoogle Scholar
  51. 51.
    Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mutand P, Alamowicz S, Domenga V, Cecillion M, Marechal E, Maclazek J, Vayssiere C, Cruaud C, Cabanis E-A, Ruchoux MM, Weissenbach J, Bach JF, Bousser M-G, Tournier-Lasserve E (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383:707–710PubMedGoogle Scholar
  52. 52.
    Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssiére C, Cruaud C, Maciazek J, Weis-senbach J, Bousser M-G, Bach J-F, Tournier-Lasserve E (1997) Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 350:1511–1515PubMedGoogle Scholar
  53. 53.
    Jung HH, Bassetti C, Tournier-Lasserve E, Vahedi K, Arnaboldi M, Arifi VB, Burgunder JM (1995) Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leucoencephalopathy: a clinicopathological and genetic study of a Swiss family. J Neurol Neurosurg Psychiat 59:138–143PubMedGoogle Scholar
  54. 54.
    Kase CSCerebral amyloid angiopathy (1994) In: Kase CS, Caplan LR (eds) Intracerebral hemorrhage. Butterworth-Heinemann, Boston, pp 179–200Google Scholar
  55. 55.
    Kobayashi Y, Momeu MY, Tominaga K, Shimoizumi H, Nihei K, Yamadisawa M, Kagava Y, Ohta S (1991) Respiration-deficient cells caused by a single point mutation in the mitochondrial trMA-leu (OUR) gene in mitochondrial myopathy, encephalopathy, lactid acidosis and stroke-like episodes (MELAS). Am J Hum Genet 49:590–599PubMedGoogle Scholar
  56. 56.
    Krayenbühl H, Yasagil G (1957) Die vaskulären Erkrankungen im Gebiet der A. vertebralis und A. basilaris. Thieme, Stuttgart, S. 20Google Scholar
  57. 57.
    Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, Bots GTAM, Luyendijk W, Frangione B (1990) Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124–1126PubMedGoogle Scholar
  58. 58.
    Leys D, Englund E, Del Ser T, Inzitari D, Fazekas F, Bornstein N, Erkinjuntee T, Bowler JV, Pantoni L, Parnetti L, De Reuck J, Ferro J, Bogousslavsky J (1999) On behalf of the European Task Force on Age-Related White Matter Changes: White matter changes in stroke patients. Relationship with stroke subtypes and outcome. Eur Neurol 42:67–75PubMedGoogle Scholar
  59. 59.
    Marie P (1901) Des foyers lacunaires de desintégration et de différents autres états cavitaires du cerveaux. Rév Méd 21:281–298Google Scholar
  60. 60.
    Marinkovic SV, Milisavljevic MM, Kovacevic MS, Stevic ZD (1985) Perforating branches of the middle cerebral artery. Microanatomy and clinical significance of their intracerebral segments. Stroke 16:1022–1029PubMedGoogle Scholar
  61. 61.
    Mas JL, Dilouya A, De Recondo Y (1992) A familial disorder with subcortical ischemic strokes, dementia, and leucoencephalopathy. Neurology 42:1015–1019PubMedGoogle Scholar
  62. 62.
    Mas JL, Lamy C (1998) Stroke impragnancy and the postportum period. In: Ginsberg D, Bogousslavsky J (eds) Cerebrovascular disease. Pathophysiology, diagnosis and management. Vol. II. Black-well Science, Oxford London Edinburgh, pp 1684–1697Google Scholar
  63. 63.
    Mass M, Bourdette D, Bernstein W, Hammerstad J (1988) Retinopathy, encephalopathy, deafness associated microangiopathy (The RED M syndrome): three new cases. Neurology 38:S215 (Abstr.)Google Scholar
  64. 64.
    Mayer SA, Tatemichi TK, Spitz JL, Desmond DW, Gamboa ET, Gropen TI (1994) Recurrent ischemie events and diffuse white matter disease in patients with pseudoxanthoma elasticum. Cerebrovasc Dis 4:294–297Google Scholar
  65. 65.
    Mohr JP (1982) Lacunes. Stroke 13:3–11PubMedGoogle Scholar
  66. 66.
    Molnar M, Neudecker S, Schroder JM (1995) Increase of mitochondria in vasa nervorum of cases with mitochondrial myopathy; Kearns-Sayre syndrome, progressive external ophthalmoplegia and MEALS. Neuropathol Appl Neurobiol 21:432–439PubMedGoogle Scholar
  67. 67.
    Monteiro MLF, Swanson RA, Copetto JR, Cuneo RA, DeArmond SJ, Prusiner SB (1985) Microangio-pathic syndrome of encephalopathy, hearing loss and retinal arteriolar occlusions. Neurology 35:1113–1121PubMedGoogle Scholar
  68. 68.
    Mosewich RK, Donat JR, DiMauro S, Ciafaloni E, Shantske S, Arasmus M, George D (1993) The syndrome of mitochondrial encephalopathy, lactid acidosis and stroke-like episodes presenting without stroke. Arch Neurol 50:275–278PubMedGoogle Scholar
  69. 69.
    Nicoll JA, Burnett C, Love S, Graham DI, Dewar D, Ironside JW, Stewart J, Vinters HV (1997) High frequency of apolipoprotein E, epsilon2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 41:716–721PubMedGoogle Scholar
  70. 70.
    Nicolle MW, McLachlan RS (1991) Microangiopathy with retinopathy, encephalopathy, and deafness (RED-M) and systemic features. Seminars in Arthritis and Rheumatism 21:123–128PubMedGoogle Scholar
  71. 71.
    Olszewski J (1962) Subcortical arteriosclerotic encephalopathy. World Neurol 3:359–375PubMedGoogle Scholar
  72. 72.
    Ostrow PT, Miller LL (1993) Pathology of small artery disease. Adv Neurol 62:93–103PubMedGoogle Scholar
  73. 73.
    Palsdottir A, Abrahamson M, Thorsteinsson L, Arnason A, Olafsson I, Grubb A (1988) Mutation in cystatin C gene causes hereditary brain hemorrhage. Lancet 2:603–604PubMedGoogle Scholar
  74. 74.
    Pantoni L, Garcia JH (1995) The significance of cerebral white matter abnormalities 100 years after Binswanger’s report. A review. Stroke 26:1293–1301Google Scholar
  75. 75.
    Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Roland LP (1984) Mitochondrial myopathy, encephalopathy, lactid acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol 16:481–488PubMedGoogle Scholar
  76. 76.
    Pessin MS, Chung CS (1995) Eales’s disease and Gröenblad-Strandberg disease (pseudoxanthoma elasticum). In: Bogousslavsky J, Caplan L (eds) Stroke syndromes. Cambridge University Press, New York Melbourne, pp 443–447Google Scholar
  77. 77.
    Radack K, Deck C, Puster G (1989) Diatary supplementation with low-dose fishoils lowers fibrinogen levels: a randomized, double-blind controlled study. Ann Int Med 111:757–758PubMedGoogle Scholar
  78. 78.
    Ragno M, Tournier-Lasserve E, Fiori MG, Manca A, Patrosso MC, Ferlini A, Sirocchi G, Trojano L, Chabriat H, Salvi F (1995) An Italian kindred with cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CA-DASIL). Ann Neurol 38:231–236PubMedGoogle Scholar
  79. 79.
    Raroque HG, Orrisson WW, Rosenberg GA (1990) Neurologic involvement in toxaemia of pragnancy: reversible MRI lesions. Neurology 40:167–169PubMedGoogle Scholar
  80. 80.
    Ringelstein EB, Mauckner A, Schneider R, Sturm W, Doering W, Wolf S, Maurin N, Wilemes K, Schlenker M, Brückmann H, Eschenfelder V (1988) Effects of enzymatic blood defibrination in subcortical arteriosclerotic encephalopathy. J Neurol Neurosurg Psychiatr 51:1051–1057PubMedGoogle Scholar
  81. 81.
    Ringelstein EB (1999) Primärprävention. In: Berlit P (Hrsg) Klinische Neurologic Springer, Berlin Heidelberg New York, S 1019–1032Google Scholar
  82. 82.
    Roberts JM, Redman CWG (1993) Preeclampsia: more than pragnancy-induced hypertention. Lancet 34:1447–1450Google Scholar
  83. 83.
    Sabbadini G, Franci A, Calandriello L, Di Biasi C, Trasimeni G, Gualdi GF, Palladini G, Manfredi M, Frontali M (1995) Cerebral autosomal dominant arteriopathy with subcortical infarcts (sic) and leucoencephalopathy (CADASIL): Clinical, neuroimaging, pathological and genetic study of a large Italian family. Brain 118:207–215PubMedGoogle Scholar
  84. 84.
    Schmidt R, Fazekas F, Kleinert G, Offenbacher H, Gindel K, Payer F, Freidel W, Niederkorn K, Lechner H (1992) Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter: a comparative study between stroke patients and normal volunteers. Arch Neurol 49:825–827PubMedGoogle Scholar
  85. 85.
    Schmidt R, Schmidt H, Fazekas F, Schumacher M, Niederkorn K, Kappeller P, Weinrauch V, Kostner GM (1997) Apoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. Stroke 28:951–956PubMedGoogle Scholar
  86. 86.
    Schneider R, Ringelstein EB, Zeumer H, Kiesewet-ter H, Jung F (1987) The role of plasma hypervis-cosity in subcortical arteriosclerotic encephalopathy (Binswanger’s disease). J Neurol 234:67–73PubMedGoogle Scholar
  87. 87.
    Schröder JM, Scilhaus B, Jörg J (1995) Identification of the characteristic vascular changes in sural nerve biopsy of a case with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leucoencephalopathy (CADASIL). Acta Neuropath 89:116–121PubMedGoogle Scholar
  88. 88.
    Schwitter J, Agosti R, Ott P, Kaiman A, Waespe W (1992) Small infarctions of cochlear, retinal, and encephalic tissue in young women. Stroke 23:903–907PubMedGoogle Scholar
  89. 89.
    Sharshar T, Lamy C, Mas JL for the Stroke in Pregnancy Study Group (1995) ncidence and causes of strokes associated with pregnancy and puerperium. Stroke 26:930–936PubMedGoogle Scholar
  90. 90.
    SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the systolic hypertension in the elderly program (SHEP). JAMA 265:3255–3264Google Scholar
  91. 90a.
    Skehan SJ, Hutchinson M, Macerlaine DP (1995) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR findings. AJNR Am J Neuroradiol 16:2115–2119PubMedGoogle Scholar
  92. 91.
    Soninnen V, Savontaus M-L (1987) Hereditary multi-infarct dementia. Europ Neurol 27:209–215Google Scholar
  93. 92.
    Sourander P, Walinder J (1977) Hereditary multiinfarct dementia. Acta Neuropath 39:247–254PubMedGoogle Scholar
  94. 93.
    SPIRIT Study Group (1997) A randomized trial of anticoagulants vs. Aspirin after cerebral ischaemia of presumed arterial origin. Ann Neurol 42:857–865Google Scholar
  95. 94.
    St. Clair D, Bolt J, Morris S, Doyle D (1995) Hereditary multi-infarct dementia unlinked to chromosome 19ql2 in a large Scottish pedigree: evidence of probable locus heretogeneity. J Med Genet 32:57–60Google Scholar
  96. 95.
    Stevens DL, Hewlett RH, Brownell B (1997) Chronic familial vascular encephalopathy. Lancet 2:1364–1365Google Scholar
  97. 96.
    Susac JO, Hardimann JM, Scihorst JB (1979) Microangiopathy of the brain and retina. Neurology 29:313–316PubMedGoogle Scholar
  98. 97.
    Susac JO (1994) Susac’s syndrome: a triad of microangiopathy of the brain and retina with hearing loss in young women. Neurology 44:591–593PubMedGoogle Scholar
  99. 97a.
    Terwind GM, Haan J, Ophoff RA, Groenen SMA, Storimans CWJM, Lanser JBK, Roos RAC, Bleeker-Wagemakers EM, Frants RR, Ferrari MD (1998) Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud’s phenomenon. Brain 121:303–316Google Scholar
  100. 98.
    Tournier-Lasserve E, Iba-Zizen MT, Romero N, Bousser MG (1991) Autosomal dominant syndrome with strokelike episodes and Leucoence-phalopathy. Stroke 22:1297–1302PubMedGoogle Scholar
  101. 99.
    Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Lathrop GM, Chabriat H, Mas J-L, Cabanis E-A, Baudrimont M, Maciazek J, Bach M-A, Bousser M-G (1993) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy maps to chromosomel9ql2. Nat Genet 3:256–259PubMedGoogle Scholar
  102. 10.
    Uenlue M, DeLange RPJ, De Silva R, Kalaria R, St Clair D (2000) Detection of complement factor B in the cerebrospinal fluid of CADASIl cases using two-dimensional electrophoreses and mass-spec-trosmetry. Neuroscience Lett (in press)Google Scholar
  103. 101.
    UKPDS I. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853Google Scholar
  104. 102.
    UKPDS II. UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–865Google Scholar
  105. 103.
    van Swieten JC, Geyskess GG, Derix MMA, Peeck BM, Ramos LNP, van Latum JC, van Gijn J (1991) Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol 30:825–830PubMedGoogle Scholar
  106. 104.
    Waltzl M (1993) Effect of heparin-induced extracorporeal low-density lipoprotein precipitation and dezafibrate on hemorheology and clinical symptoms in cerebral multi-infarct disease. Hä-mostasis 23:192–202Google Scholar
  107. 105.
    Weiller C, Ringelstein EB, Reiche W, Thron A, Buell U (1990) The large striatocapsular infarct. A clinical and pathophysiological entity. Arch Neurol 47:1085–1091Google Scholar
  108. 106.
    Wielaard R, Bornebroek M, Ophoff RA, Winter-Warnars HAO, Scheltens Ph, Frants RR, Ferrari MD, Haan J (1995) A four-generation Dutch family with cerebral autosomal-dominant arteriopathy with subcortical infarct and leucoencephalopathy (CADASIL), linked to chromosomel9pl3. Clin Neurol Neurosurg 97:307–313PubMedGoogle Scholar
  109. 107.
    Wildemann B, Schülin C, Storch-Hagenlocher B, Hacke W, Dithmar S, Kirchhof K, Jansen O, Breitbart A (1996) Susac’s syndrome: improvement with combined antiplatelet and calcium antagonist therapy. Letter to the Editor. Stroke 27:149–150PubMedGoogle Scholar
  110. 108.
    World Health Organization (WHO) Guidelines Subcommittee (1999) International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 17:151–183Google Scholar
  111. 109.
    Zierz S, Meeßen S, Jerusalem F (1989) Lactatund Pyruvat-Blutspiegel in der Diagnostik mitochondrialer Myopathien. Nervenarzt 60:545–548PubMedGoogle Scholar
  112. 110.
    Zunker P, Ley-Pozo J, Louwen F, Schuierer G, Holzgreve VW, Ringelstein EB (1995) Cerebral hemodynamics in pre-eclampsia/eclampsia syndrome. Ultrasound Obstet Gynecol 6:411–415PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • E. B Ringelstein

There are no affiliations available

Personalised recommendations